Press Releases

Mentice receives an order of EUR 1,733,200 for simulation solutions from a world leading MedTech company

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader and existing customer of Mentice, has signed an agreement to acquire Mentice VIST® simulation solutions for EUR 1,733,200. The majority of the Mentice VIST® systems are to be deployed in the main APAC markets.

Mentice enters agreement to acquire all substantial assets from Biomodex, a leading provider of 3D-printed vessels and flow systems

Mentice AB (STO: MNTC), a world leader in simulation solutions for image guided interventional therapies, announced today that it has entered into an agreement to acquire all substantial assets from Paris-based company Biomodex for a purchase price of 200,000 EUR, following a decision by their board to dissolve operations. The global Biomodex business reached a total turnover of 2.2 million EUR in 2022.

Mentice appoints Ulrika Drotz Voksepp as new Chief Financial Officer

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, appoints Ulrika Drotz Voksepp as CFO, effective January 2nd, 2024

Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2024

At the Annual General Meeting held on 11 May 2023, it was resolved to adopt instructions and rules of procedure for the Nomination Committee, according to which the Nomination Committee shall consist of the Chairman of the Board and three members representing the three largest shareholders in terms of voting rights as of September 30.

Mentice publishes the company’s interim report for the period July – Sept 2023

THIRD QUARTER WITH CONTINUED STRONG GROWTH, POSITIVE EBITDA AND IMPROVED CASHFLOW

Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg.

Mentice receives an order of 1,008,000 USD for simulation solutions from a world-leading MedTech company

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader has signed an agreement to acquire Mentice VIST® simulation solutions for 1,008,000 USD.

Mentice has received a significant order from a key distributor in APAC

Mentice (publ), a global leader in simulation solutions for image-guided interventional therapies, announced today that a prominent distributor in the APAC region has signed an agreement to acquire Mentice VIST® simulation solutions for 592,000 EUR.

Mentice strengthens leadership team with the appointment of Chief Operating Officer (COO)

Mentice AB (STO: MNTC) announces the appointment of Jonatan Sjöström to its Executive Management Group as Chief Operating Officer (COO).

Mentice announces the latest release of Ankyras in the EU

Mentice, a healthcare technology company, proudly announces the latest release of Ankyras in the EU. This clinical decision support application has been designed to support interventional neuroradiologists in selecting the most optimal flow diverters for treating intracranial aneurysms. The updated version of Ankyras offers an intuitive and secure solution for planning, storing, and sharing clinical treatment plans online, offline, and on mobile platforms.

Mentice appoints Henrik Hang as Interim Chief Financial Officer CFO

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, appoints Henrik Hang as interim CFO, effective July 21st, 2023.

Mentice publishes the company’s interim report for the period April – June 2023

Continued strong performance during the second quarter

Correction: Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 20 at 10:00 CEST.

Correction made to previous reference to EU Market Abuse Regulation

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on July 20 at 10:00 CEST.

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson.

Mentice Expands Cooperation in China with Siemens Healthineers

Gothenburg, Sweden

Mentice announces resignation of Chief Financial Officer

Mentice's CFO, Gunilla Andersson, has decided to leave Mentice. Gunilla will formally leave the Company at the end of August and be replaced by an interim CFO until a new CFO has been appointed.

Mentice receives an order of 2.4 million USD for simulation solutions from a top 20 global MedTech company

Sweden-Gothenburg, May 22nd, 2023

Mentice receives an order of 578,000 USD for simulation solutions from a world leading MedTech company

Sweden-Gothenburg, May 17th, 2023

Communique from annual general meeting in Mentice AB

An annual general meeting was held in Mentice AB on 11 May 2023. Below follows a summary of the resolutions made at the meeting.

Mentice Opens Strategic Hub for Software Development

The newly established Mentice Spain S.L. office in the heart of Barcelona, Spain, will serve as an additional hub for Mentice group’s software development, with an initial focus on the recently acquired, CE-marked Ankyras® intracranial aneurysm decision support solution.

Mentice receives an order of 690,000 USD for simulation solutions from a Top 20 global MedTech company

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® simulation solutions for 690,000 USD.

Mentice publishes the company’s interim report for the period January – March 2023

Increased sales and positive EBITDA conclude a good start for 2023.

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on April 27 at 10:00 CEST

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask CEO Göran Malmberg and CFO Gunilla Andersson questions.

Annual shareholders’ meeting in Mentice AB

The shareholders in Mentice AB, reg. no. 566556-4241, (the “Company”), are hereby invited to attend the annual shareholders’ meeting to be held on 11 May 2023 at 2.00 p.m. at Radisson Blu Scandinavia Hotel Gothenburg, Södra Hamngatan 59, 401 24 Gothenburg.

Mentice receives an order of USD 655,000 for simulation solutions from Medtronic

Mentice (publ), Gothenburg, a world leader in simulation solutions for image-guided interventional therapies, announced today that Medtronic, Dublin, a global healthcare technology leader, has signed an agreement to acquire Mentice VIST® and physiological flow system simulation solutions for 655,000 USD.

Mentice receives an order of USD 652,000 for VIST® simulation solutions from Medtronic

Sweden-Gothenburg, February 15, 2023

Mentice publishes the company’s year-end report for the period January–December 2022

Continued strong order intake and improved cashflow

Mentice’s CEO Göran Malmberg to present the company’s Year-end Report Q4 2022 at a earnings call on February 3rd at 10:00 CET

Mentice AB (STO: MNTC) announces that the company will present its year-end report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson.